José
Palacios Calvo
Profesor/a Titular Universidad
![Foto de Gema](/img/nophoto.png)
Gema
Moreno Bueno
Gema Moreno Bueno-rekin lankidetzan egindako argitalpenak (66)
2024
2023
-
Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases
Cancers, Vol. 15, Núm. 6
2022
-
Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context
Frontiers in Cell and Developmental Biology, Vol. 10
-
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Journal of Personalized Medicine, Vol. 12, Núm. 11
2019
-
Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness
Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858
2017
-
Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer
Journal of Pathology, Vol. 241, Núm. 4, pp. 475-487
2016
-
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Oncotarget, Vol. 7, Núm. 35, pp. 56295-56308
2015
-
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503
-
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer
International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873
-
Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT
International Journal of Cancer, Vol. 136, Núm. 4, pp. E62-E73
2014
-
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403
-
A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition
Journal of Pathology, Vol. 232, Núm. 3, pp. 319-329
2013
-
Endometrial carcinoma: Molecular alterations involved in tumor development and progression
Oncogene, Vol. 32, Núm. 4, pp. 403-413
-
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis
Human Pathology, Vol. 44, Núm. 2, pp. 244-254
2012
-
The EMT signaling pathways in endometrial carcinoma
Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720
-
The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells
Oncogene, Vol. 31, Núm. 16, pp. 2049-2061
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543
-
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
EMBO Molecular Medicine, Vol. 3, Núm. 9, pp. 528-544
-
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma
Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80
2010
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Molecular Cancer, Vol. 9